Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITY (Details Narrative)

v3.24.2.u1
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Derivative liability $ 0   $ 0   $ 39,000  
Gain (Loss) on Sale of Derivatives 11,000 $ 0 $ 39,000 $ 0    
Probability of decreased repayment of loan     0.00%   55.00%  
Loan Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Probability of decreased repayment of loan     0.00%   10.00%  
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Secured debt           $ 20,000,000
Derivative Liability Level 3 [Member] | K2 HealthVentures LLC [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Derivative liability $ 0   $ 0      
Gain (Loss) on Sale of Derivatives     $ 39,000